The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson's disease.
Stefano MartiniFranca MarinoLuca MagistrelliElena ContaldiMarco CosentinoCristoforo ComiPublished in: Pilot and feasibility studies (2023)
ClinicalTrials.gov ID NCT05173701. Registered 08 November 2021.